Label: AHA BHA BLEMISH CONTROL AND EXFOLIATING SERUM- salicylic acid serum liquid
- NDC Code(s): 85439-0101-1
- Packager: Banuskin, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated April 3, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
- Warnings
- When using this product
- Keep out of reach of children.
-
Direction
- Cleanse skin thoroughly before applying product.
- Cover the entire affected area with a thin layer one to three times daily.
- Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
- Other Information
-
Inactive Ingredient
Aqua/Water/Eau, Isopentyldiol, Squalane, Dipropylene Glycol, Hydroxypropyl Starch Phosphate, Mandelic Acid, Niacinamide, Sodium Hydroxide, Citric Acid, Succinic Acid, Phenoxyethanol, Lactobacillus ferment lysate, Xanthan Gum, Alpha-glucan oligosaccharide, Hydrogenated Lecithin, Sclerotium Gum, Lecithin, Pullulan, Allantoin, Bisabolol, Sodium Phytate, Potassium Sorbate, Sodium Benzoate, Silica, 1,2-Hexanediol, Hydroxyacetophenone, Sodium Hyaluronate, Ethylhexylglycerin.
- Questions or comments?
- DOSAGE & ADMINISTRATION
- SPL UNCLASSIFIED SECTION
- Labels
-
INGREDIENTS AND APPEARANCE
AHA BHA BLEMISH CONTROL AND EXFOLIATING SERUM
salicylic acid serum liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:85439-0101 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 2 g in 100 mL Inactive Ingredients Ingredient Name Strength NIACINAMIDE (UNII: 25X51I8RD4) CITRIC ACID (UNII: 2968PHW8QP) XANTHAN GUM (UNII: TTV12P4NEE) PHENOXYETHANOL (UNII: HIE492ZZ3T) HYDROXYACETOPHENONE (UNII: G1L3HT4CMH) ISOPENTYLDIOL (UNII: 19NOL5474Q) SQUALANE (UNII: GW89575KF9) HYDROXYPROPYL STARCH (UNII: 9M44R3409A) SODIUM HYDROXIDE (UNII: 55X04QC32I) PULLULAN (UNII: 8ZQ0AYU1TT) BISABOLOL (UNII: 24WE03BX2T) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) ALPHA-GLUCAN OLIGOSACCHARIDE (UNII: S95658MI3W) SODIUM BENZOATE (UNII: OJ245FE5EU) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM HYALURONATE (UNII: YSE9PPT4TH) WATER (UNII: 059QF0KO0R) MANDELIC ACID (UNII: NH496X0UJX) SODIUM PHYTATE (UNII: 88496G1ERL) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) DIPROPYLENE GLYCOL (UNII: E107L85C40) SUCCINIC ACID (UNII: AB6MNQ6J6L) SCLEROTIUM GUM (UNII: 2X51AD1X3T) ALLANTOIN (UNII: 344S277G0Z) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:85439-0101-1 30 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 04/15/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M006 04/15/2025 Labeler - Banuskin, Inc. (119398280) Registrant - Banuskin, Inc. (119398280)
